Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. EC Healthcare
  6. News
  7. Summary
    2138   KYG3037S1021

EC HEALTHCARE

(2138)
  Report
Delayed Hong Kong Stock Exchange  -  03:09 2022-12-05 am EST
6.160 HKD   +12.61%
11/24EC Healthcare's April-September Profit Falls on Higher Expenses
MT
11/24EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services
AQ
11/23EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Payable on 20 January 2023
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EC HEALTHCARE : APPOINTS MR. AU TSUN AS GROUP INDEPENDENT NON-EXECUTIVE DIRECTOR

09/02/2022 | 12:09pm EST

EC HEALTHCARE APPOINTS MR. AU TSUN

AS GROUP INDEPENDENT NON-EXECUTIVE DIRECTOR

(1 September 2022, Hong Kong) EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, announces that Mr. Au Tsun ("Mr. Au") has been appointed as an independent non-executive Director of the Company with effect from 1 September 2022. Mr. Au is also appointed as the chairman of the Remuneration Committee, and a member of the Audit Committee and the Nomination Committee.

In addition, Mr. Lam Chi Hang Josekin ("Mr. Lam") has resigned as an independent non-executive director of the Company with effect from 1 September 2022 due to other work commitments. Mr. Lam has also ceased to be the chairman of the Remuneration Committee, and a member of the Audit Committee and the Nomination Committee.

The biographical details of Mr. Au are set out as follow:

Mr. Au, aged 42, is currently working in CTF Education Group as Chief Operating Officer. He oversees the operations, management and strategy implementation of Hong Kong and Mainland China regional offices, including finance, IT and human resources functions. Mr. Au is also the Interim Executive Director of Victoria Educational Organisation.

Before that, Mr. Au worked in Ernst & Young ("EY") during the period from 2002 to 2012 and from 2015 to 2020 and held various management roles. The most senior position held by Mr. Au at EY was assurance, and advisory Partner under Financial Accounting and Advisory Services ("FAAS"), where he was also the Asia Pacific leader in System, Process and Automation under FAAS. During the period from 2013 to 2015, Mr. Au served as the Regional Vice President of Asia for PRGX, a US-listed global data analytics company.

Mr. Au obtained a degree of Bachelor of Economics and Finance from the University of Hong Kong in 2002. Mr. Au is a member of the Hong Kong Institute of Certified Public Accountants, and is also a member of the New Hampshire State Board of Accountancy in the US and American Institute of Certified Public Accountants.

Mr. Au serves on the Audit Committee of UNICEF Hong Kong, school council member of Sheng Kung Hui primary schools, School Supervisor of DSC International School and Board Member of Hong Kong Education City wholly owned by the HKSAR Government.

- End -

EC Healthcare Appoints Mr. Au Tsun As Group Independent Non-Executive Director

1 September 2022, Page 2

About EC Healthcare

EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL, NEW MEDICAL CENTER and Prime Medical Centres, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021

Disclaimer

EC Healthcare published this content on 01 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 September 2022 16:08:01 UTC.


ę Publicnow 2022
All news about EC HEALTHCARE
11/24EC Healthcare's April-September Profit Falls on Higher Expenses
MT
11/24EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly D..
AQ
11/23EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Pa..
CI
11/23EC Healthcare Reports Earnings Results for the Half Year Ended September 30, 2022
CI
11/11EC Healthcare Provides Earnings Guidance for the Six Months Ended 30 September 2022
CI
10/16EC Healthcare Expects Sales Volume for Six Months through September to Jump 17%
MT
10/16EC Healthcare expects a record-high semi-annual sales volume in first half of FY23 of n..
AQ
10/03Team Expert Buys 7.5% Stake in EC Healthcare Unit; EC Healthcare Shares Fall 4%
MT
10/03EC Healthcare Unit Buys 60% Stake in Pioneer Evolution for $4.6 Million; Shares Drop 4%
MT
10/02EC Healthcare Acquires Multi-Disciplinary Healthcare Services Chain in Hong Kong
AQ
More news
Financials
Sales 2023 3 722 M 479 M 479 M
Net income 2023 216 M 27,8 M 27,8 M
Net Debt 2023 - - -
P/E ratio 2023 33,3x
Yield 2023 2,02%
Capitalization 7 276 M 937 M 937 M
Capi. / Sales 2023 1,95x
Capi. / Sales 2024 1,60x
Nbr of Employees 2 557
Free-Float 38,8%
Chart EC HEALTHCARE
Duration : Period :
EC Healthcare Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EC HEALTHCARE
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 6,16 HKD
Average target price 7,51 HKD
Spread / Average Target 21,9%
EPS Revisions
Managers and Directors
Lyn Wade Lu Co-Chief Executive Officer & Executive Director
Chi Fai Tang Chairman & Co-Chief Executive Officer
Heung Wing Lee Finance Director
Kun Shing Luk Non-Executive Director & Chief Information Officer
Ka Ki Wong Executive Director & Chief Investment Officer
Sector and Competitors